Comparison of Standard vs. Accelerated Corneal Crosslinking

Recruiting now · Phase 2/Phase 3

Conditions studied: Keratoconus, Ectasia Corneal

In brief

The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.

Key facts

Study ID

NCT03922542

Run by

Price Vision Group

People needed

510

Starts

2019-04-16

Expected to finish

2026-07-01

Last updated by the study team

2025-07-31

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented keratoconus or ectasia after refractive surgery

You may not qualify if…

• Insufficient corneal thickness
• Ocular condition that may predispose the eye to complications
• History of chemical injury or delayed epithelial healing
• Condition that would interfere with or prolong epithelial healing
• Known sensitivity to treatment medications
• Pregnancy

Where it is running

• Price Vision Group — Indianapolis, Indiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.